Viva Cyte Suite Sagtewareplatform deur Livia Stevenin

Die ontwerp Viva Cyte Suite Sagtewareplatform deur Livia Stevenin is 'n hoogs gewaardeerde wenner van die baie prestigieuese 2025 A' Design Award in Silwer in die Koppelvlak-, Interaksie- en Gebruikerservaring-ontwerp-kompetisiekategorie.

SilwerKoppelvlak· 2025

Viva Cyte Suite Sagtewareplatform

deur Livia Stevenin

Kliënt: Cellply

Wenner van die A' Design Award in Silwer in die Koppelvlak-kategorie

56,621

Geverifieerde Toekenningswenner

Verifieer Toekenningsstatus vir #168358

Besoek Webwerf Bekyk by A' Design Award Persverklaring Toekenningskenteken

Kleure

Die Ontwerp

Oor Viva Cyte Suite Sagtewareplatform

Viva Cyte is 'n gevorderde sagtewareplatform wat ontwerp is om selterapieontwikkeling te stroomlyn deur outomatisering, hoë deursetanalise en 'n intuïtiewe gebruikerservaring te integreer. Dit bestaan uit Beheersagteware (CSW) vir die bestuur van biologiese toetse en Analitiese Sagteware (ASW) vir die onttrekking van betekenisvolle insigte. KI-gedrewe outomatisering verminder menslike foute, verbeter akkuraatheid en verhoog bruikbaarheid, wat navorsers in staat stel om komplekse werkvloeie doeltreffend te navigeer terwyl dit terapeutiese vooruitgang versnel.

Die Erkenning

Oor die A' Design Award in Silwer

Viva Cyte Suite Sagtewareplatform is 'n wenner van die A' Design Award in Silwer, 'n buitengewoon prestigieuse erkenning wat toegeken word aan topklas-, pragtige en indrukwekkende ontwerpe. Wenners in Silwer is geweldig briljante en uiters kreatiewe werke wat die uitstaande kundigheid, talent en skerpsinnigheid van hul ontwerpers illustreer. Daar word verwag dat Viva Cyte Suite Sagtewareplatform 'n wonderlike vertoonstuk is wat merkwaardig professioneel en diepgaande innoverend is. Hierdie ontwerp wat die A' Design Award in Silwer gewen het, is 'n hoogs noemenswaardige, bewonderde uitvinding wat die grense van kuns, wetenskap, ontwerp en tegnologie bevoordeel en uitbrei. Viva Cyte Suite Sagtewareplatform is 'n wyd beny skepping wat begeertes oproep, positiewe gevoelens bring en verbasing en verwondering wek.

Agter die Ontwerp

Persstel

Krediete, spanlede en tegniese besonderhede verskaf deur die ontwerper.

Unieke Eienskappe: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Afmetings & Verpakking: Design: Figma
Front-end: React JS
Design System: Bento
Etikette: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Produksietegnologie: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Ontwerpuitdaging: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Navorsing: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Inspirasie: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Projekduur: The project started in January 2022 in Milan and finished in August 2024.
Bedryfsvloei: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Spanlede: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Beeldkrediete: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),